Earlier this week, APC released an extensive statement on compounding copies of FDA approved drugs when those drugs are in shortage. The statement focuses in particular on semaglutide.
In the spirit of embracing the joy we feel as pharmacy compounders, the APC logo was recently refreshed to include our new “Compounding the Joy” tagline.
Medisca is supporting APC's “Compounding the Joy of Living” campaign by matching all individual contributions, dollar for dollar, up to $100,000.
The latest in APC’s suite of briefing documents for prescribers is available and it summarizes regulation governing the use of compounded medications for racehorses.
Heeding APC's recommendations, the Board voted at its May 8 hearing to strike this language from the rules, removing this potentially burdensome change.
FDA Commissioner Dr. Robert Califf recently acknowledged the importance of compounding for addressing drug shortages during emergencies.
Compounding pharmacies using OutcomeMD, a patient-reported outcomes (PROs) tool, can now join our user group. As an APC member, you can access this tool at a special members-only subscription rate.
Showcasing patient testimonials in your compounding pharmacy's waiting area can have a significant impact on building trust with your patients and improving their experience.
Three state boards of pharmacy recently issued licensee communications that contained incorrect information about FDA guidance on shortage drug compounding by 503A pharmacies.
FOLLOW US
